DIABETIC MACULAR EDEMA (DME)

This study is testing a new eye injection called EYE103 to see if it works as well or better than an existing drug (ranibizumab) for diabetic macular edema, a swelling in the back of the eye that causes vision loss in people with diabetes. About 960 participants will receive inje…

This early-stage study is testing a new drug called EYE201, given as three injections into the eye, to see if it's safe and might help control vision loss. It's for adults with vision problems from diabetic macular edema, age-related macular degeneration, or a retinal vein blocka…

This study aims to find out which of two common eye injections works better for improving vision in people with diabetic macular edema, a condition where diabetes causes fluid buildup in the eye, leading to vision loss. Researchers will compare aflibercept and bevacizumab in abou…

This study is testing whether a new eye drop called KHK4951 can safely reduce swelling in the retina and improve vision for people with diabetic macular edema (DME). It involves about 150 adults with DME and compares the eye drops to a standard treatment. The main goal is to see …

This study looks back at existing health records to understand how doctors in Japan use aflibercept 8 mg, an injection for two common eye conditions that cause blurry vision. Researchers will analyze data from about 3,000 patients who already received this approved treatment as p…